Abstract
Using an 'intelligent' tablet bottle which, unknown to the patient, electronically records the times of opening we have assessed the compliance of patients with prescribed oral medication. The compliance pattern of 12 patients receiving low dose etoposide for small cell lung cancer was monitored over 25 treatment periods, representing a total of 298 days. The data were expressed as overall compliance (OC), defined as the observed number of bottle openings as a percentage of the prescribed number of doses, and as two indices representing daily and hourly irregularities in the times of opening. The OC had a mean (+/- s.d.) value of 93.2% (+/- 12%) over the 25 treatment periods, and is similar to that which we have reported in a group of lymphoma patients (Lee et al., 1992). By means of a self assessed diary card we monitored the physical and mental state of the patients. Although we found significant associations between the compliance measures and some of the diary card measures, the magnitude of the observed effects would be of little practical consequence. We conclude that, in our group of patients, inadequate compliance with oral chemotherapy would not account for any significant lack of clinical response.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carney D. N. The pharmacology of intravenous and oral etoposide. Cancer. 1991 Jan 1;67(1 Suppl):299–302. doi: 10.1002/1097-0142(19910101)67:1+<299::aid-cncr2820671315>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Einhorn L. H. Daily oral etoposide in the treatment of cancer. Semin Oncol. 1991 Feb;18(1 Suppl 2):43–47. [PubMed] [Google Scholar]
- Geddes D. M., Dones L., Hill E., Law K., Harper P. G., Spiro S. G., Tobias J. S., Souhami R. L. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer. 1990 Apr;26(4):484–492. doi: 10.1016/0277-5379(90)90022-l. [DOI] [PubMed] [Google Scholar]
- Greco F. A., Johnson D. H., Hainsworth J. D. Chronic oral etoposide. Cancer. 1991 Jan 1;67(1 Suppl):303–309. doi: 10.1002/1097-0142(19910101)67:1+<303::aid-cncr2820671316>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- Lebovits A. H., Strain J. J., Schleifer S. J., Tanaka J. S., Bhardwaj S., Messe M. R. Patient noncompliance with self-administered chemotherapy. Cancer. 1990 Jan 1;65(1):17–22. doi: 10.1002/1097-0142(19900101)65:1<17::aid-cncr2820650106>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Lee C. R., Nicholson P. W., Souhami R. L., Deshmukh A. A. Patient compliance with oral chemotherapy as assessed by a novel electronic technique. J Clin Oncol. 1992 Jun;10(6):1007–1013. doi: 10.1200/JCO.1992.10.6.1007. [DOI] [PubMed] [Google Scholar]
- Levine A. M., Richardson J. L., Marks G., Chan K., Graham J., Selser J. N., Kishbaugh C., Shelton D. R., Johnson C. A. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987 Sep;5(9):1469–1476. doi: 10.1200/JCO.1987.5.9.1469. [DOI] [PubMed] [Google Scholar]
- Nicholson P. W. Electronic monitor for patient compliance with drug therapy. Med Biol Eng Comput. 1991 Nov;29(6):607–608. doi: 10.1007/BF02446105. [DOI] [PubMed] [Google Scholar]
- Slevin M. L. Low-dose oral etoposide: a new role for an old drug? J Clin Oncol. 1990 Oct;8(10):1607–1609. doi: 10.1200/JCO.1990.8.10.1607. [DOI] [PubMed] [Google Scholar]
- Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]